{"id":55368,"date":"2025-10-31T08:08:32","date_gmt":"2025-10-31T12:08:32","guid":{"rendered":"https:\/\/stockmarketwatch.com\/stock-market-news\/earnings-season-highlights-abbvie-dominion-report-strong-q3-imperial-oil-sees-mixed-results-cboe-initiates-strategic-restructuring\/55368\/"},"modified":"2025-10-31T08:08:32","modified_gmt":"2025-10-31T12:08:32","slug":"earnings-season-highlights-abbvie-dominion-report-strong-q3-imperial-oil-sees-mixed-results-cboe-initiates-strategic-restructuring","status":"publish","type":"post","link":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/earnings-season-highlights-abbvie-dominion-report-strong-q3-imperial-oil-sees-mixed-results-cboe-initiates-strategic-restructuring\/55368\/","title":{"rendered":"Earnings Season Highlights: AbbVie, Dominion Report Strong Q3, Imperial Oil Sees Mixed Results, CBOE Initiates Strategic Restructuring"},"content":{"rendered":"<h2>Key Takeaways<\/h2>\n<ul>\n<li><strong>AbbVie (<a href=\"\/stock\/ABBV\">ABBV<\/a>)<\/strong> significantly surpassed third-quarter earnings and revenue estimates, driven by strong performance from Skyrizi and Rinvoq, leading the company to boost its full-year adjusted EPS guidance and raise its quarterly dividend.<\/li>\n<li><strong>Dominion (<a href=\"\/stock\/D\">D<\/a>)<\/strong> reported a robust Q3, exceeding both operating revenue and operating EPS expectations, and subsequently narrowed its full-year 2025 operating earnings guidance.<\/li>\n<li><strong>Imperial Oil (<a href=\"\/stock\/IMO\">IMO<\/a>)<\/strong> presented a mixed third quarter, with earnings per share falling short of analyst estimates despite a strong beat on total revenue and a 3.4% year-over-year increase in average production.<\/li>\n<li><strong>CBOE Global Markets (<a href=\"\/stock\/CBOE\">CBOE<\/a>)<\/strong> announced a strategic overhaul, initiating sales processes for its Australian and Canadian operations while discontinuing certain listings efforts in the U.S. and Europe, alongside reporting solid Q3 financial results.<\/li>\n<li>The <strong>European Union<\/strong> is actively addressing critical policy areas, including future collaboration in the semiconductor industry, defense programs, and the potential removal of export bans on Ukrainian food products.<\/li>\n<\/ul>\n<h2>Corporate Earnings Dominate News Flow<\/h2>\n<p>Pharmaceutical giant <strong>AbbVie (<a href=\"\/stock\/ABBV\">ABBV<\/a>)<\/strong> delivered an impressive third-quarter performance, reporting adjusted earnings per share of <strong>$1.86<\/strong>, comfortably exceeding the estimated <strong>$1.79<\/strong>. Net revenue reached <strong>$15.78 billion<\/strong>, surpassing the <strong>$15.59 billion<\/strong> estimate. Key growth drivers included <strong>Skyrizi<\/strong> revenue of <strong>$4.71 billion<\/strong> (versus an estimated <strong>$4.58 billion<\/strong>) and <strong>Rinvoq<\/strong> revenue of <strong>$2.184 billion<\/strong>. Despite <strong>Humira<\/strong> revenue falling to <strong>$993 million<\/strong> (below the <strong>$1.14 billion<\/strong> estimate), the company boosted its full-year adjusted EPS outlook to a range of <strong>$10.61 to $10.65<\/strong>, up from the previous <strong>$10.38 to $10.58<\/strong>. AbbVie also increased its quarterly dividend to <strong>$1.73 per share<\/strong> from <strong>$1.64<\/strong>.<\/p>\n<p>Energy major <strong>Imperial Oil (<a href=\"\/stock\/IMO\">IMO<\/a>)<\/strong> reported mixed results for its third quarter. The company&#39;s EPS came in at <strong>C$1.07<\/strong>, significantly below the estimated <strong>C$1.85<\/strong>. However, total revenue and other income reached <strong>C$12.05 billion<\/strong>, comfortably beating the <strong>C$9.6 billion<\/strong> estimate. Average production saw a healthy increase of <strong>3.4% year-over-year<\/strong>, reaching <strong>462,000 barrels of oil equivalent per day (BOE\/D)<\/strong>.<\/p>\n<p>Utility giant <strong>Dominion (<a href=\"\/stock\/D\">D<\/a>)<\/strong> also had a strong third quarter, with operating revenue of <strong>$4.527 billion<\/strong>, outperforming the <strong>$4.285 billion<\/strong> estimate. Operating EPS stood at <strong>$1.06<\/strong>, above the <strong>$0.98<\/strong> estimate, while reported EPS was <strong>$1.16<\/strong>. The company narrowed its full-year 2025 operating earnings guidance range to <strong>$3.33 to $3.48 per share<\/strong>.<\/p>\n<h2>CBOE Global Markets Announces Strategic Restructuring<\/h2>\n<p><strong>CBOE Global Markets Inc (<a href=\"\/stock\/CBOE\">CBOE<\/a>)<\/strong> unveiled a strategic initiative to streamline its operations. The company is initiating a sales process for its <strong>CBOE Australia<\/strong> and <strong>CBOE Canada<\/strong> businesses. Concurrently, CBOE will discontinue its U.S. and European corporate listings efforts and reduce costs associated with its U.S. and European ETP listings businesses, as well as CBOE Europe Derivatives. These strategic moves come as CBOE reported robust third-quarter financials, including revenue of <strong>$1,141.7 million<\/strong>, adjusted EBITDA of <strong>$409 million<\/strong> (with a <strong>67.5%<\/strong> margin), and adjusted EPS of <strong>$2.67<\/strong>.<\/p>\n<h2>EU Engages on Key Policy Fronts<\/h2>\n<p>In European policy news, EU Commissioner <strong>Virkkunen<\/strong> held a meeting with semiconductor industry CEOs yesterday to discuss future collaboration and development within the critical sector. Separately, EU Commissioner <strong>Kubilius<\/strong> is in discussions with the British Defense Secretary regarding the <strong>SAFE program<\/strong>. Furthermore, an EU Commission spokesman indicated that the EU sees no justification in prolonging export bans regarding Ukrainian food products and is actively looking to remove these restrictions.<\/p>\n<h2>Currency Markets Watch Critical GBPUSD Level<\/h2>\n<p>On the currency front, the <strong>GBPUSD<\/strong> pair is closely watching the <strong>1.3140 area<\/strong>, a significant technical level that represents the 38.2% Fibonacci retracement and has acted as a key low in May, August, and October. <em>A breach below this level could signal further downside for the British Pound against the U.S. Dollar.<\/em><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Key Takeaways AbbVie (ABBV) significantly surpassed third-quarter earnings and revenue estimates, driven by strong performance from Skyrizi and Rinvoq, leading [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":50383,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"rank_math_schema_Article":[],"rank_math_focus_keyword":[],"rank_math_description":[],"financial_data_references":[],"stock_symbols_mentioned":[],"footnotes":""},"categories":[5012],"tags":[5866,1578,6350,1807,7570,3470,7573,3826,11753,12455,5027,13769,5030,5039,5042,5775],"class_list":["post-55368","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-breaking-news","tag-d","tag-cboe","tag-abbvie","tag-earnings","tag-imperial-oil","tag-financials","tag-imo","tag-abbv","tag-q3","tag-gbpusd","tag-semiconductors","tag-dominion","tag-energy","tag-eu","tag-ukraine","tag-pharmaceuticals"],"_links":{"self":[{"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/posts\/55368","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/comments?post=55368"}],"version-history":[{"count":0,"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/posts\/55368\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/media\/50383"}],"wp:attachment":[{"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/media?parent=55368"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/categories?post=55368"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/tags?post=55368"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}